ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NORMAN ALLEN MD

Cardiovascular Disease

12,972

$632K

429
317 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 32%

$49
Average prescription price

Avg: $73

FELTON ANDERSON M.D.

Cardiovascular Disease

8,746

$538K

310
232 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 32%

$62
Average prescription price

Avg: $73

JAMES OLIVER M.D.

Cardiovascular Disease

5,163

$282K

186
137 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 32%

$55
Average prescription price

Avg: $73

ALFRED BURRIS M.D.

Cardiovascular Disease

4,727

$191K

254
194 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 32%

$40
Average prescription price

Avg: $73

RAMIN OSKOUI MD

Cardiovascular Disease

3,883

$450K

382
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 32%

$116
Average prescription price

Avg: $73

DINESH JOSHI M.D.

Cardiovascular Disease

3,376

$167K

299
273 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 32%

$50
Average prescription price

Avg: $73

HERMAN GIST M.D.

Cardiovascular Disease

3,362

$353K

242
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 32%

$105
Average prescription price

Avg: $73

BOISEY BARNES MD

Cardiovascular Disease

2,881

$218K

133
94 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 32%

$76
Average prescription price

Avg: $73

PATRICIA DAVIDSON MD

Cardiovascular Disease

2,816

$249K

187
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 32%

$88
Average prescription price

Avg: $73

BERNICE JACKSON M.D.

Cardiovascular Disease

2,507

$152K

100
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 32%

$61
Average prescription price

Avg: $73

ANASTASIA GYFTOPOULOS MD

Cardiovascular Disease

2,491

$112K

96
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 32%

$45
Average prescription price

Avg: $73

MARIA RUMSEY MD

Cardiovascular Disease

2,461

$103K

264
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 32%

$42
Average prescription price

Avg: $73

AMJAD RASUL M.D.

Cardiovascular Disease

1,901

$101K

115
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 32%

$53
Average prescription price

Avg: $73

EDWARD MORRIS MD

Cardiovascular Disease

1,631

$104K

211
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 32%

$64
Average prescription price

Avg: $73

GEORGE BREN M.D.

Cardiovascular Disease

1,620

$125K

137
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 32%

$77
Average prescription price

Avg: $73

THOMAS PINDER M.D.

Cardiovascular Disease

1,514

$96.5K

156
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 32%

$64
Average prescription price

Avg: $73

GEORGE RUIZ MD

Cardiovascular Disease

1,473

$586K

114
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 32%

$398
Average prescription price

Avg: $73

GEORGIA WILLIE CARNEGIE MD

Cardiovascular Disease

1,452

$87.7K

131
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 32%

$60
Average prescription price

Avg: $73

JOEL ROSENBERG MD

Cardiovascular Disease

1,430

$152K

178
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 32%

$106
Average prescription price

Avg: $73

DEBORAH WILLIAMS MD

Cardiovascular Disease

1,362

$68.3K

96
66 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 32%

$50
Average prescription price

Avg: $73

JOSEPH QUASH M.D.

Cardiovascular Disease

1,326

$74.1K

123
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 32%

$56
Average prescription price

Avg: $73

PRAFULLA MEHROTRA MD

Cardiovascular Disease

1,231

$51.7K

50
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 32%

$42
Average prescription price

Avg: $73

DIMITRI CASSIMATIS M.D.

Cardiovascular Disease

1,141

$63.6K

143
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 32%

$56
Average prescription price

Avg: $73

SAMER NAJJAR M.D.

Cardiovascular Disease

1,095

$220K

101
44 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 32%

$201
Average prescription price

Avg: $73

MICHAEL BLUNDA MD

Cardiovascular Disease

1,046

$52.8K

98
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 32%

$50
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank